Your Health, We Care
The targeted drug Sotorasib is a pioneering KRASG12C inhibitor, with the active ingredient Sotorasib and development code AMG510. It was previously accelerated for approval in the United States.
At present, the drug has been approved in 35 countries worldwide through the KRASG12C clinical development program.
Sotorasib, a small molecule inhibitor targeting the KRAS G12C gene mutation in n···【more】
Release date：2024-07-09Recommended：163
